Yunkang Group Limited (2325.HK)
2325.HK Stock Price Chart
Explore Yunkang Group Limited interactive price chart. Choose custom timeframes to analyze 2325.HK price movements and trends.
2325.HK Company Profile
Discover essential business fundamentals and corporate details for Yunkang Group Limited (2325.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
18 May 2022
Employees
1.25K
Website
https://www.yunkanghealth.comCEO
Yong Zhang
Description
Yunkang Group Limited operates as a medical operation service provider in the People's Republic of China. The company offers diagnostic testing services for medical institution alliances, including setting up or upgrading diagnostic centers, the establishment of standard operating procedures for diagnostic testing, diagnostic consultation and staff training, procurement of equipment, smart internet of things, and logistics assistance. It also provides diagnostic outsourcing services comprising pathology tests; infectious disease diagnostic tests, including hepatitis B virus, tuberculosis, human papilloma virus, EB virus, rabies virus, and nucleic acid tests for respiratory pathogens; genetic reproduction and screening tests; and routine diagnostic tests for chronic kidney, blood, autoimmune, endocrine metabolism, and other diseases. In addition, the company offers diagnostic testing services for financial institutions and insurance companies, including personalized diagnostic testing, medical report consultation, and hospital referral services; information technology, medical logistics, and medical equipment procurement; healthcare technology development; and project investment. It provides its services through independent clinical laboratories and on-site diagnostic centers. Yunkang Group Limited was founded in 2008 and is headquartered in Guangzhou, the People's Republic of China.
2325.HK Financial Timeline
Browse a chronological timeline of Yunkang Group Limited corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 28 Mar 2025
Dividend declared on 4 Jul 2024
A dividend of $0.02 per share was announced, adjusted to $0.02. The dividend was paid on 28 Aug 2024.
Earnings released on 30 Jun 2024
EPS came in at -$0.11 , while revenue for the quarter reached $203.91M .
Earnings released on 31 Mar 2024
EPS came in at -$0.11 , while revenue for the quarter reached $205.73M .
Earnings released on 31 Dec 2023
EPS came in at -$0.14 , while revenue for the quarter reached $228.60M .
Earnings released on 30 Sept 2023
EPS came in at -$0.13 , while revenue for the quarter reached $221.76M .
Dividend declared on 4 Jul 2023
A dividend of $0.22 per share was announced, adjusted to $0.22. The dividend was paid on 25 Aug 2023.
Earnings released on 30 Jun 2023
EPS came in at $0.04 , while revenue for the quarter reached $257.28M .
Earnings released on 31 Mar 2023
EPS came in at $0.04 , while revenue for the quarter reached $272.30M .
Earnings released on 31 Dec 2022
EPS came in at $0.13 , while revenue for the quarter reached $1.35B .
Earnings released on 30 Sept 2022
EPS came in at $0.13 , while revenue for the quarter reached $1.31B .
Dividend declared on 23 Aug 2022
A dividend of $0.09 per share was announced, adjusted to $0.09. The dividend was paid on 16 Sept 2022.
Earnings released on 11 Aug 2022
EPS came in at $0.51 , while revenue for the quarter reached $1.60B .
Earnings released on 29 Jun 2022
EPS came in at $0.54 , while revenue for the quarter reached $1.66B .
2325.HK Stock Performance
Access detailed 2325.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.